Clinical Trials Browser

NCT04266093 2026-06-04

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix

NCT07545746 2026-06-02

ASCEND

Phase 2 Not yet recruiting

140 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07606677 2026-05-26

Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women

Not yet recruiting

1,465 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07520188 2026-05-19

CASCADE3002

Not yet recruiting

3,500 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07593066 2026-05-18

PRIORITY

Not yet recruiting

700 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06519994 2026-05-14

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 2 Completed

120 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07572396 2026-05-14

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Phase 2 Recruiting

45 enrolled

Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT07576842 2026-05-08

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

Phase NA Not yet recruiting

750 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07454915 2026-05-06

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Phase 2 Recruiting

138 enrolled

Gynecologic

Uterine Cervical Dysplasia